Professor Alison Birtle is a consultant clinical oncologist, Manchester Academic Health Science Centre (MAHSC) Honorary Clinical Professor in the Faculty of Biology, Medicine and Health at the University of Manchester, and Honorary Clinical Professor at the University of Central Lancashire, specialising in the treatment of urological cancers. She is part of the education faculty of the European Society of Medical Oncology. Her MD thesis was in PSA-negative prostate cancers at the Institute of Urology, London. She is an Advisor to “Macmillan Cancer Support” on patient information for prostate, bladder, and testicular tumours, Trustee and Medical Advisor to “Fight Bladder Cancer”, and Secretary to the British Uro-oncology Group (BUG).
Professor Birtle has been Clinical Research Lead for Lancashire and South Cumbria Cancer Research Network (CRN), and more recently, Associate Clinical Lead for Cancer Research, and since March 2018, Speciality Group Lead for Cancer Research for North West Coast CRN. She is a former member of the prostate clinical study group and stepped down as Chair of the Bladder/Renal NIHR clinical study group in 2018 after two terms. She remains a member of the Advanced Bladder Cancer Subgroup. In 2021, she was appointed as a member of the RCR Academic Committee for Clinical Oncology. Professor Birtle has published widely and lectures nationally and internationally.
In 2018, she was awarded one of the NHS STAR awards given by NHS England and the NHS Confederation as part of the 70th anniversary celebrations of the NHS. Professor Birtle was also awarded NWCCRN Research Practitioner of the Year in 2018, and, more locally, runner-up in “Lancashire Doctor of the Year”. She has won numerous other awards, including for the best oncology abstract at the European Urology Association Congress 2018, best plenary abstract at the American Society of Clinical Oncology GU Symposium 2018, best poster at the British Association of Urological Surgeons Annual meeting 2018, and Researcher of the Year in the North West Coast Research and Innovation Awards.
Professor Birtle has been Principal Investigator and Chief Investigator on numerous urology clinical trials and is the Chief Investigator on the POUT trial, the results of which have been incorporated into European Urology Guidelines. She is passionate about patient access to clinical trials and believes in the mantra of a trial for every patient. Professor Birtle combines full time NHS work with a passion for research, and for musical theatre.
EM-113523 - Date of preparation: October 2022